We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
Out of stock
This item is currently unavailable
Gone for 312 days. Could come back at any time — we're watching for you.
Out of stock 312 days · last price £795
The 2021-2026 World Outlook for Major Depressive Disorder (MDD) Therapeutics
One email. No newsletter. No nudges.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 724 days · 724 data points (no recent data)
Historical
Generating forecast…
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
↑ Price chart
when this has been cheap or pricey
when this has been cheap or pricey
↑ Forecast
where the price is heading next
where the price is heading next
↓ Statistics
all-time high & low, recent range
all-time high & low, recent range
↑ Price alert
name your number, we'll email you
name your number, we'll email you
Price Distribution
Price distribution over 724 days • 1 price levels
Price Analysis
Most common price: £795 (724 days, 100.0%)
Price range: £795 - £795
Price levels: 1 different prices over 724 days
Description
This study covers the world outlook for major depressive disorder (MDD) therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for major depressive disorder (MDD) therapeutics. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.
Product Specifications
- Format
- paperback
- ASIN
- B082JQ64KT
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 13 February 2020
- Listed Since
- 13 December 2019
Similar Products You Might Like
98% match
The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in the United States
£520.00
25 Aug 2026
98% match
The 2026-2031 World Outlook for Antidepressant Drugs
£885.00
15 Aug 2026
98% match
The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders in China
£495.00
20 Oct 2026
98% match
The 2021-2026 World Outlook for Antidepressants
£795.00
12 Aug 2026
98% match
The 2026-2031 World Outlook for Antidepressant Pharmaceuticals
£885.00
26 Sep 2026
98% match
The 2016-2021 Outlook for Antidepressant Pharmaceuticals in Japan
£595.00
10 Sep 2026
98% match
The 2026-2031 World Outlook for Antidepressants
£885.00
15 Aug 2026
98% match
The 2023-2028 Outlook for Antidepressants for Major Depressive Disorders for US Zip Codes
£490.00
20 Oct 2026
97% match
The 2026-2031 World Outlook for Antidepressant and Anti-Anxiety Drugs
£885.00
15 Aug 2026
97% match
The 2023-2028 Outlook for Antidepressants for Anxiety Disorders in the United States
£520.00
25 Aug 2026
97% match
The 2026-2031 World Outlook for Antidepressants for Anxiety Disorders
£885.00
19 Aug 2026
97% match
The 2023-2028 Outlook for Anxiety Disorders and Depression Treatments in the United States
£520.00
23 Aug 2026
97% match
The 2026-2031 World Outlook for Antidepressants for Major Depressive Disorders
£885.00
14 Aug 2026
96% match
Diagnostik und Verlauf depressiver Störungen: Differenzierung der Depression - Einbezug von Persönlichkeit und Temperament - multidimensionale Diagnostik
£88.00
07 Sep 2026
96% match
Recent Advances and Challenges in the Treatment of Major Depressive Disorder: 1456 (Advances in Experimental Medicine and Biology, 1456)
Springer
£128.60
03 Sep 2026
96% match
The 2023-2028 Outlook for Anxiety Disorders and Depression in the United States
£520.00
21 Aug 2026
96% match
Therapies for Treatment-Resistant Depression: Neuropharmacology and Neurostimulation
Elsevier
£135.69
23 Sep 2026
96% match
The 2021-2026 World Outlook for Psychotherapeutic Agents Excluding Tranquilizers and Antidepressants
£795.00
11 Aug 2026
96% match
Prevention and Early Treatment of Depression Through the Life Course (Depression and Personality)
Springer
£43.96
26 Sep 2026
96% match
Recent Advances in Depression: Complications, Awareness, and Management: (Mental Illnesses and Treatments Series)
Nova
Price unavailable
96% match
Translational Research Methods for Major Depressive Disorder: 179 (Neuromethods, 179)
Humana
£170.00
27 Aug 2026
96% match
Depressive Disorders: Integrated and Unified Psychotherapy Approaches
Routledge
£145.00
24 Sep 2026
96% match
Psychology and Phenomenology of Depression: 2 (Depression: Understanding the Silent Epidemic)
Price unavailable
96% match
Depression: A Silent Culprit in Health and Disease
Bentham Science Publishers
£73.08
14 Oct 2026